Viewing Study NCT00433602



Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00433602
Status: COMPLETED
Last Update Posted: 2013-06-12
First Post: 2007-02-08

Brief Title: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Study Overview

Official Title: TEACH Survey Thrombo-Embolism And Chemotherapy A Prospective Survey on the Incidence of Venous Thromboembolic Events During Chemotherapy for Solid Tumors
Status: COMPLETED
Status Verified Date: 2013-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Chemotherapy may cause blood clots to form in the thigh leg and lung This study may help doctors understand how often blood clots occur in patients undergoing chemotherapy

PURPOSE This clinical trial is studying how often blood clots occur in patients undergoing chemotherapy for solid tumors including colorectal cancer stomach cancer lung cancer ovarian cancer pancreatic cancer prostate cancer or metastatic breast cancer
Detailed Description: OBJECTIVES

Determine the incidence of venous thromboembolic events ie deep vein thrombosis andor pulmonary embolism in patients undergoing chemotherapy for solid tumors

OUTLINE This is a prospective multicenter survey

Patients undergo observation beginning on day 1 of chemotherapy and continuing for up to 3 months in the absence of symptomatic confirmed deep vein thrombosis or pulmonary embolism use of anticoagulant therapy for more than 5 days as curative treatment or initiation of thromboprophylaxis for any reason Patients undergo bilateral compression ultrasound of the lower limbs at baseline and at 3 months or at an earlier timepoint if indicated

PROJECTED ACCRUAL A total of 2000 patients will be accrued for this study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
SANOFI-AVENTIS-EORTC-90051 None None None
EORTC-90051 None None None